David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLMS
2851
DELISTED
Calamos Asset Management, Inc.
CLMS
| $414K | ﹤0.01% |
48,757
-4,346
| -8% | -$38.6K |
|
|
SP
2852
DELISTED
SP Plus Corporation
SP
| $413K | ﹤0.01% |
17,147
+204
| +1% | +$4.71K |
|
2853
Incyte
INCY
$26.5B
| $412K | ﹤0.01% |
5,689
-46,356
| -89% | -$3.45M |
|
2854
PUT
Marvell Technology
MRVL
$218B
| $412K | ﹤0.01% |
40,000
| – | – |
|
2855
PUT
Baxter International
BAX
$13.5B
| $411K | ﹤0.01% |
10,000
-71,700
| -88% | -$2.73M |
|
2856
KRONOS Worldwide
KRO
$999M
| $410K | ﹤0.01% |
71,719
+28,146
| +65% | +$147K |
|
|
JMI
2857
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
| $410K | ﹤0.01% |
57,144
+39,212
| +219% | +$249K |
|
2858
Verisk Analytics
VRSK
$25.1B
| $407K | ﹤0.01% |
5,091
-63,023
| -93% | -$4.6M |
|
|
CUTR
2859
DELISTED
Cutera, Inc.
CUTR
| $407K | ﹤0.01% |
36,176
+22,084
| +157% | +$251K |
|
|
CORR
2860
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $406K | ﹤0.01% |
+20,171
| New | +$304K |
|
2861
PUT
HSBC
HSBC
$355B
| $405K | ﹤0.01% |
+14,591
| New | +$431K |
|
2862
Plug Power
PLUG
$3.17B
| $405K | ﹤0.01% |
197,703
+9,229
| +5% | +$17.3K |
|
|
BXLT
2863
PUT
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $404K | ﹤0.01% |
10,000
-71,700
| -88% | -$2.84M |
|
2864
Celestica
CLS
$37.9B
| $403K | ﹤0.01% |
36,741
+13,034
| +55% | +$132K |
|
2865
Essex Property Trust
ESS
$18.8B
| $402K | ﹤0.01% |
1,718
+600
| +54% | +$132K |
|
|
YELL
2866
DELISTED
Yellow Corporation Common Stock
YELL
| $401K | ﹤0.01% |
43,058
-213,657
| -83% | -$2.03M |
|
|
YZC
2867
DELISTED
Yanzhou Coal Mining
YZC
| $399K | ﹤0.01% |
+75,700
| New | +$336K |
|
2868
Hope Bancorp
HOPE
$1.78B
| $398K | ﹤0.01% |
26,170
+3,823
| +17% | +$57.2K |
|
|
KW
2869
DELISTED
Kennedy-Wilson Holdings
KW
| $397K | ﹤0.01% |
18,127
-2,597
| -13% | -$51.4K |
|
|
XENT
2870
DELISTED
Intersect ENT, Inc
XENT
| $397K | ﹤0.01% |
20,894
-108,893
| -84% | -$1.97M |
|
2871
Extreme Networks
EXTR
$2.96B
| $394K | ﹤0.01% |
126,788
-327,167
| -72% | -$1.01M |
|
2872
Natera
NTRA
$48.2B
| $393K | ﹤0.01% |
+41,302
| New | +$349K |
|
|
FOMX
2873
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $393K | ﹤0.01% |
60,294
+5,906
| +11% | +$38.1K |
|
2874
Consumer Portfolio Services
CPSS
$198M
| $391K | ﹤0.01% |
92,506
-23,980
| -21% | -$103K |
|
2875
Descartes Systems
DSGX
$6.65B
| $391K | ﹤0.01% |
20,100
-15,200
| -43% | -$267K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.